The National Institutes of Health said that it would review a needle exchange study it had agreed to sponsor in Alaska after a consumer health group charged that the research was unethical.
The three-year study, which was to begin recruiting patients in December, is intended to see if intravenous users of illicit drugs can cut their risk of being infected with disease viruses if they exchange their dirty, used needles and syringes for clean ones. The group objected that half of the drug users, those in the control group, would be denied access to the clean needles.
The Public Citizen’s Health Research Group asked the federal research agency to withdraw its support of the study because the trial was “highly unethical” in its design.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.